Sign In
test

Santhosh Palani

Psp Research Llc

Assets Managed
$187.882M
Holdings
75
Last Quarter
2026 - Q2
Filed Date
5d ago
Growth Rate
32.94%(2Q avg: 28.23%)
Sustained Growth
2 quarters

Portfolio positions

This chart displays the top 10 holdings in Psp Research Llc's 2026 - Q2 portfolio, based on their 13F SEC filing, out of a total of 75 positions.

Assets under management

The assets under management (AUM) of Psp Research Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2026 - Q2, they manage 187.882M in assets, with a quarterly growth rate of 32.94% and a 2-quarter average growth rate of 28.23%. The portfolio is managed by Santhosh Palani, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
XBI
Spdr S&p Biotech Etf
Recent Activity
Increased 100.08%
48.02%
$90.203M
570,000 shares@ $158.25 avg price
SGOV
Ishares 0-3 Month Treasury B
Recent Activity
37.51%
$70.469M
700,000 shares@ $100.67 avg price
RPRX
Royalty Pharma Plc- Cl A
Recent Activity
0.33%
$616,770
11,000 shares@ $56.07 avg price
NRIX
Nurix Therapeutics Inc
Recent Activity
Decreased -12.89%
0.33%
$606,500
25,000 shares@ $24.26 avg price
INCY
Incyte Corp
Recent Activity
0.32%
$600,808
5,300 shares@ $113.36 avg price
ARGX
Argenx Se - Adr
Recent Activity
0.32%
$594,701
641 shares@ $927.78 avg price
IRON
Disc Medicine Inc
Recent Activity
0.32%
$585,120
8,000 shares@ $73.14 avg price
RAPP
Rapport Therapeutics Inc
Recent Activity
0.32%
$583,380
14,000 shares@ $41.67 avg price
RARE
Ultragenyx Pharmaceutical In
Recent Activity
Decreased -23.07%
0.31%
$567,630
17,000 shares@ $33.39 avg price
TRVI
Trevi Therapeutics Inc
Recent Activity
0.3%
$559,500
30,000 shares@ $18.65 avg price

1-10 of 75